GL1X · GenesisL1 explorer

Research workbench

Omi-38 Fab in complex with SARS-cov-2 beta spike rbd (local refinement)

Analyse Omi-38 Fab in complex with SARS-cov-2 beta spike rbd (local refinement) in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7ZR8
Type
protein
Length
471 residues
Chains
3
Method
electron microscopy
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Spike GLYCOPROTEIN,FIBRITIN; Omi-38 Fab heavy chain; Omi-38 Fab light chain
UniProt
P0DTC2
Ligands
NAG
Pockets
5 · best druggability 0.55

Structure

electron microscopy · 3 distinct chains · 7% helix, 37% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ASpike GLYCOPROTEIN,FIBRITINprotein24511% helix, 29% strandP0DTC2
HOmi-38 Fab heavy chainprotein1183% helix, 54% strand—
LOmi-38 Fab light chainprotein1083% helix, 38% strand—

Ligands and binding sites

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11720.550.8027empty
21090.370.7423empty
3640.290.7412empty
4530.270.7415empty
5500.250.7311empty

Interfaces

3 interfaces between chains.

  • H–L · 874 Ų buried · 6 hydrogen bonds · protein-protein
  • A–H · 593 Ų buried · 12 hydrogen bonds · protein-protein
  • A–L · 448 Ų buried · 7 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 6 disulfide, 1 glycan (disulfide, N-glycosylation).

Compared structures

  • 7ZR8 · OMI-38 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE RBD (local refinement) · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.